Arbutus Biopharma Corporation (NASDAQ:ABUS)

CAPS Rating: 2 out of 5

ABUS News and Commentary

Caps

How do you think ABUS will perform against the market?

Add Stock to CAPS Watchlist

All Players

94 Outperform
7 Underperform
 

All-Star Players

24 Outperform
5 Underperform
 

Wall Street

3 Outperform
1 Underperform
 

Top ABUS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Sparticus501 (< 20)
Submitted October 11, 2014

EBOLA! This company is key to the fight against the spread of this deadly disease.

TMFMattyA (99.90)
Submitted September 24, 2014

Tekmira's stock has nearly tripled since the start of the Ebola outbreak in West Africa this summer. The company has an experimental drug (in Phase 1 trials) that is designed to treat Ebola -- and various governments have allowed its use in the… More

ABUS VS S&P 500 (SPY)

Fools bearish on ABUS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ABUS.

Recs

0
Member Avatar adamicius (< 20) Submitted: 4/14/2017 9:43:55 AM : Outperform Start Price: $3.30 ABUS Score: +88.20

tapping into a potentially very lucrative hepatitis B market plus a pipeline of other potential assets. As with any research stage biotech, it's a speculative investment and should be sized accordingly.

Recs

0
Member Avatar Turtlebale (50.84) Submitted: 8/26/2016 2:44:18 PM : Underperform Start Price: $3.68 ABUS Score: -57.84

HepB competition

Recs

0
Member Avatar oscillation (77.00) Submitted: 1/24/2016 7:45:18 PM : Outperform Start Price: $3.58 ABUS Score: +45.28

nev

Leaderboard

Find the members with the highest scoring picks in ABUS.

Score Leader

portefeuille

portefeuille (98.91) Score: +564.48

The Score Leader is the player with the highest score across all their picks in ABUS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. skyrocket29 64.34 1/3/2017 Outperform 1Y $2.45 +177.55% +22.08% +155.47 0 Comment
DoubleBagel 47.50 1/23/2017 Outperform 5Y $2.58 +164.08% +21.70% +142.38 0 Comment
gunterle 66.48 1/5/2017 Outperform 5Y $2.65 +156.60% +21.49% +135.11 0 Comment
spgem < 20 10/28/2014 Underperform 3M $18.03 -62.29% +39.59% +101.87 1 Comment
MMCapitalMgmt 99.94 10/30/2014 Underperform 5Y $16.59 -59.01% +39.05% +98.06 1 Comment
jackbot 93.89 8/6/2014 Underperform 5Y $13.92 -51.15% +43.76% +94.91 0 Comment
adamicius < 20 4/17/2017 Outperform 5Y $3.30 +106.06% +17.86% +88.20 1 Comment
portefeuille 98.91 2/10/2016 Outperform 5Y $2.98 +128.19% +46.34% +81.85 0 Comment
portefeuille6 99.57 9/2/2016 Outperform 5Y $3.76 +80.85% +25.96% +54.89 0 Comment
portefeuille2 99.65 9/2/2016 Outperform 5Y $3.81 +78.48% +25.75% +52.73 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackchardan 61.52 11/30/2016 Outperform NS $2.75 +147.27% +23.96% +123.31 0 Comment
TrackJimCramer 85.44 9/5/2014 Underperform 3W $18.56 -63.36% +36.61% +99.97 0 Comment
TrackStifel 93.94 1/31/2014 Outperform NS $13.49 -49.59% +55.20% -104.80 0 Comment
TrackMaximGroup 65.54 10/7/2013 Outperform NS $10.18 -33.20% +64.10% -97.30 0 Comment

Featured Broker Partners


Advertisement